MARÍA JOSÉ
SERRANO FERNÁNDEZ
Ikertzailea 2022-2023 tartean
JOSÉ LUIS
GARCÍA PUCHE
Ikertzailea 2018-2019 tartean
JOSÉ LUIS GARCÍA PUCHE-rekin lankidetzan egindako argitalpenak (17)
2022
-
Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective
Molecular Genetics and Genomics, Vol. 297, Núm. 3, pp. 859-871
2020
-
Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients
Scientific Reports, Vol. 10, Núm. 1
2019
-
Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents
Cells, Vol. 8, Núm. 11
-
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
Breast Cancer Research, Vol. 21, Núm. 1
2018
-
Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients
Journal of Translational Medicine, Vol. 16, Núm. 1
2017
-
A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: Biological and clinical implications of EGFR, AR and SNPs
Oncotarget, Vol. 8, Núm. 41, pp. 70472-70482
-
Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers
European Journal of Cardio-thoracic Surgery, Vol. 52, Núm. 1, pp. 55-62
-
Circulating tumor cells: Markers and methodologies for enrichment and detection
Methods in Molecular Biology (Humana Press Inc.), pp. 283-303
-
Significance of EGFR expression in circulating tumor cells
Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 285-296
2016
-
Circulating tumor cells identify early recurrence in patients with non-small cell lung cancer undergoing radical resection
PLoS ONE, Vol. 11, Núm. 2
-
Dormant circulating tumor cells in prostate cancer: Therapeutic, clinical and biological implications
Current Drug Targets, Vol. 17, Núm. 6, pp. 693-701
-
Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC)
Surgery (United States), Vol. 159, Núm. 3, pp. 728-735
2015
-
Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell status
Tumor Biology, Vol. 36, Núm. 2, pp. 711-718
-
MiRNA in situ hybridization in circulating tumor cells - MishCTC
Scientific Reports, Vol. 5
2014
-
EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
Oncotarget, Vol. 5, Núm. 17, pp. 7486-7497
2013
-
CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
International Journal of Cancer, Vol. 133, Núm. 10, pp. 2398-2407
2012
-
Biomarkers characterization of circulating tumour cells in breast cancer patients
Breast Cancer Research, Vol. 14, Núm. 3